spirogermanium has been researched along with concanavalin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badger, AM; DiMartino, MJ; Hanna, N; Lee, JC; Mirabelli, CK; Muirhead, KA | 1 |
| Badger, AM; DiMartino, M; Mirabelli, CK | 1 |
2 other study(ies) available for spirogermanium and concanavalin a
| Article | Year |
|---|---|
Antiarthritic and immunoregulatory activity of spirogermanium.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis; Arthritis, Experimental; Auranofin; Aurothioglucose; Concanavalin A; Fluorescence; Germanium; Immunosuppressive Agents; Indomethacin; Interleukin-1; Interleukin-2; Macrophages; Male; Monocytes; Organometallic Compounds; Rats; Rats, Inbred Lew; Spiro Compounds; T-Lymphocytes, Regulatory | 1986 |
Generation of suppressor cells in normal rats by treatment with spirogermanium, a novel heterocyclic anticancer drug.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Concanavalin A; Germanium; Kinetics; Lymphocyte Depletion; Male; Organometallic Compounds; Rats; Rats, Inbred Lew; Spiro Compounds; Spleen; T-Lymphocytes, Regulatory | 1985 |